The Pro Medicus Limited (ASX: PME) share price is on course to end the week on a positive note.
In early trade, the health imaging technology company’s shares were up 4.5% to $49.34.
The Pro Medicus share price has since pulled back but remains up by 2% currently.
Why is the Pro Medicus share price charging higher?
The catalyst for the rise in the Pro Medicus share price on Friday has been the announcement of a major new contract win.
According to the release, the company’s US business, Visage Imaging, has signed a $32 million, eight-year contract with Inova Health System.
Inova is the leading non-profit healthcare provider in Northern Virginia. It has 20,000+ team members supporting more than two million patient visits each year through an integrated network of hospitals, primary, and specialty care practices, emergency and urgent care centres, outpatient services, and destination institutes.
The release notes that the agreement is based on a transactional licensing model and will see the company’s Visage 7 Enterprise Imaging Platform implemented throughout Inova and Fairfax Radiology. This will provide a unified diagnostic imaging platform across both networks.
Pro Medicus advised that planning for the rollout is to commence immediately, with initial go-lives targeted for the second half of the calendar year.
The implementation will be fully deployed in the public cloud, which management notes is a favourable trend that has taken a foothold in the global healthcare IT market.
Management commentary
Pro Medicus CEO, Dr Sam Hupert, commented: “This is our fourth major contract in the IDN space in less than 18 months which further underpins the strong momentum we continue to build not only in this segment of market but also the North American market as a whole.”
“Our pipeline remains strong. Deals like this confirm our view that Visage 7, with its proven cloud native technology provides us with a significant strategic advantage that addresses these opportunities across a growing segment of the market both in North America and other regions.”
The post Pro Medicus share price jumps on $32m contract news appeared first on The Motley Fool Australia.
Should you invest $1,000 in Pro Medicus right now?
Before you consider Pro Medicus, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Pro Medicus wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- 2 stellar ASX growth shares analysts rate as buys
- Growth will be back! Expert picks 7 ASX shares to buy now
- Experts say it’s time to buy these beaten-up, quality ASX shares
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/cvg3Tm2
Leave a Reply